Gaurav Shah - 17 May 2023 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
CEO, Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Gaurav Shah
Issuer symbol
RCKT
Transactions as of
17 May 2023
Net transactions value
-$88,108
Form type
4
Filing time
19 May 2023, 16:05:38 UTC
Previous filing
16 May 2023
Next filing
14 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale $88,108 -4,122 -0.78% $21.38 521,642 17 May 2023 Direct F1
holding RCKT Common Stock 207,897 17 May 2023 By Spouse
holding RCKT Common Stock 198,341 17 May 2023 By Gaurav D. Shah Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.